NCT02647528

A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Sadick Research Group · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A Randomized, Blinded, Single-Centered, Placebo-Controlled Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DEVICE	Chromogenix Regenlite Transform Treatment	Pulse Dyed Laser - 7mm spot size 3-3.6 J/cm2
DEVICE	Chromogenix Regenlite Transform Placebo	Pulse Dyed Laser - 7mm spot size 0 J/cm2

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-04-01
• Completion: 2016-04-01
• First posted: 2016-01-06
• Last updated: 2016-12-06

Locations

1 site across 1 country: United States